logo-loader
Proactive Group

Investor Update: Sareum reports positive early-stage data for cancer drug

Top stories this morning from the Proactive Investors UK newsroom.

Avacta Group PLC (LON:AVCT) has said it will go to clinic “well ahead of original plans” with a drug candidate that combines its binding protein technology with chemotherapy.  The group's tumour microenvironment activated drug conjugates (TMAC) are a ground-breaking new form of cancer immunotherapy.

Argo Blockchain PLC (LON:ARB) has reported “significantly better” trading conditions since early May and has raised expectations for its second quarter on the back of improving prices in the cryptocurrency market. The crypto mining services group said in a trading update that its results for May were “materially ahead” of internal budgets, reflecting an improvement in market conditions as well as the earlier than expected delivery of crypto mining hardware.

WideCells (LON:WDC) says its Iconic Labs new media business has agreed a deal and begun work on a consulting and marketing services engagement with a UK based financial services business.  The relationship’s on a long-term retainer basis, with initial revenues over the first year expected to exceed £1 million.

Sareum Holdings (LON:SAR) has announced that Sierra Oncology’s reported positive preliminary clinical data from its two first-in-human Phase 1/2 studies. 

Benchmark Holdings PLC (LON:BMK) said it expects its full-year results to meet market estimates after delivering a 23% rise in adjusted earnings (EBITDA) in the first half. The aquaculture health, nutrition and genetics firm posted adjusted EBITDA of £7.5mln for the first half on revenue of £78.3mln, up 3.4% on a year ago.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Eve Sleep and Simba abandon merger plans

Headlines from the Proactive UK newsroom. Mattress makers Eve Sleep (LON:EVE) and Simba have abandoned their plans for a merger. Eve Sleep’s board decided now is not the right time for the deal.  Investment management software group StatPro (LON:SOG) has recommended a cash takeover...

9 minutes ago

2 min read